Global Digital Pathology Market

May 2024 | 110 pages | ID: G10FC07D28A2EN
Evolve Business Intelligence

Abstracts

Global Digital Pathology Market By Product (Scanners, Software, Storage and Communication Systems), By End User (Educational, Clinical, Pharma & Biotech Companies), By Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2020 t-2033

The global Digital Pathology market was valued at $956.3 Million in 2023 and is anticipated t-grow at a CAGR of 9.81% from 2024 t-2034. This growth is attributed t-several macr-and microeconomic factors such as

• Increase in prevalence of cancer

The surge in cancer prevalence stands as a pivotal driving force behind the rapid expansion of the Digital Pathology Market. With cancer emerging as a pervasive global health challenge, characterized by a continuous rise in new cases, there is an escalating need for advanced diagnostic and treatment approaches. Digital pathology, epitomized by the digitization of traditional tissue slides, offers a transformative solution. By harnessing computer technology, it empowers pathologists with enhanced diagnostic capabilities and streamlined workflow efficiencies. This digitized approach facilitates expedited and precise cancer diagnoses, crucial for prompt treatment planning and improved patient outcomes. Moreover, the advent of digital pathology transcends geographical boundaries, enabling remote consultation and collaboration among pathologists and specialists worldwide. This seamless exchange of expertise fosters multidisciplinary approaches t-cancer care, further elevating diagnostic accuracy and patient management standards. Additionally, the integration of digital pathology with other healthcare technologies, such as electronic health records and laboratory information systems, enhances the overall diagnostic ecosystem. In essence, the escalating prevalence of cancer underscores the indispensable role of digital pathology in modern healthcare. As healthcare systems grapple with the burgeoning burden of cancer, the adoption of digital pathology solutions emerges as a cornerstone strategy in the quest for enhanced diagnostic precision, operational efficiency, and ultimately, improved patient outcomes.

Further several factors restraining the market growth include

• High cost associated with digital pathology

The substantial financial commitment required for healthcare institutions t-adopt and integrate digital pathology solution is expected t-pose challenge t-market growth. This cost encompasses various components, from the initial investment in hardware and software procurement t-ongoing expenses for training, maintenance, and regulatory compliance. The significant upfront capital required for equipment acquisition, software development, and infrastructure setup can be particularly daunting for organizations with limited financial resources. Additionally, ongoing expenses for training programs, software updates, and technical support further compound the financial burden. Consequently, smaller healthcare facilities and practices may find it challenging t-justify the investment in digital pathology, limiting market penetration. Despite these challenges, technological advancements and increasing competition among vendors are gradually driving down costs, making digital pathology more accessible. Furthermore, the long-term benefits of improved diagnostic accuracy, operational efficiency, and enhanced patient care outcomes may ultimately outweigh the initial investment, motivating healthcare organizations t-overcome cost barriers and embrace digital pathology solutions.

Rapid technological advancements and collaborations and alliances in the Digital Pathology market are expected t-generate higher avenues during the forecast period.

In the wake of the COVID-19 pandemic, supply chain disruptions have led t-supply shortages or lower demand in the Digital Pathology market. The pandemic has caused a decline in new orders and a corresponding decrease in End Userion.

This section will analyze how COVID-19 has impacted supply chains, leading t-shortages and lower demand for Digital Pathology.

In terms of COVID-19 impact, the Digital Pathology market report als-includes the following data points:

• Impact on Digital Pathology market size
• Operating Weights Trend, Preferences, and Budget Impact
• Regulatory Framework/Outdoor Policies
• Key Players' Strategy t-Tackle Negative Impact/Post-COVID Strategies
• Opportunity in the Digital Pathology market

Key Insight in the report:

The global Digital Pathology market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and End Users.

Our report covers extensive competitive intelligence which includes the following data points:

• Business Overview
• Business Segment Data
• Financial Data
• End User Segment Analysis and Specification
• Recent Development and Company Strategy Analysis
• SWOT Analysis

Digital Pathology Market Segmentation:

• Product
• Scanners
• Software
• Storage and Communication Systems
• End User
• Educational
• Clinical
• Pharma & Biotech Companies
• Application
• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Training & Education

Region/ Countries Covered:

• North America
• US
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• BeNeLux
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• Australia
• India
• South Korea
• Thailand
• Indonesia
• Malaysia
• Rest of Asia Pacific
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of Middle East & Africa

Key Players Analyzed in the Report:

• Leica Biosystems Nussloch GmbH
• Hamamatsu Photonics Inc.
• Koninklijke Philips N.V
• Olympus Corporation
• Hoffmann-La Roche Ltd
• Mikroscan Technologies Inc.
• Inspirata, Inc.
• Epredia (3DHISTECH Ltd.)
• Visiopharm A/S
• Huron Technologies International Inc.

Contents

CHAPTER 1. EXECUTIVE SUMMARY

CHAPTER 2. SCOPE OF THE STUDY

2.1. Market Definition
2.2. Market Scope & Segmentation
  2.2.1. Objective of Report

CHAPTER 3. EVOLVE BI METHODOLOGY

3.1. Data Collection & Validation Approach
3.2. Market Size Estimation and Forecast

CHAPTER 4. MARKET INSIGHTS AND TRENDS

4.1. Value Chain Analysis
  4.1.1. Raw Materials
  4.1.2. Manufacturing
  4.1.3. Distribution Channel
  4.1.4. End User
4.2. Porter’s Five Forces Analysis
  4.2.1. Bargaining Power of Buyers
  4.2.2. Bargaining Power of Suppliers
  4.2.3. Threat of New Entrant
  4.2.4. Threat of Substitute
  4.2.5. Industry Rivalry
4.3. COVID-19 Impact and Post-COVID Scenario on Digital Pathology Market
  4.3.1. Impact of COVID-19
  4.3.2. Government Support and Industry Revival Policies
  4.3.3. Post COVID Trend

CHAPTER 5. MARKET DYNAMICS

5.1. Introduction
5.2. Drivers
  5.2.1. Increase in prevalence of cancer
  5.2.2. Rise in the demand for accurate diagnostics
5.3. Restraints
  5.3.1. High cost associated with digital pathology systems
5.4. Opportunity
  5.4.1. Rapid technological advancements in digital pathology systems

CHAPTER 6. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT

6.1. Introduction
  6.1.1. Scanners
  6.1.2. Software
  6.1.3. Storage and Communication Systems

CHAPTER 7. GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER

7.1. Introduction
  7.1.1. Educational
  7.1.2. Clinical
  7.1.3. Pharma & Biotech Companies

CHAPTER 8. GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION

8.1. Introduction
  8.1.1. Teleconsultation
  8.1.2. Disease Diagnosis
  8.1.3. Drug Discovery
  8.1.4. Training & Education

CHAPTER 9. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION

9.1. Introduction
9.2. North America
  9.2.1. North America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  9.2.2. North America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
  9.2.3. North America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  9.2.4. North America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.2.5. US
    9.2.5.1. US: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.2.5.2. US: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.2.5.3. US: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.2.6. Canada
    9.2.6.1. Canada: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.2.6.2. Canada: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.2.6.3. Canada: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.2.7. Mexico
    9.2.7.1. Mexico: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.2.7.2. Mexico: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.2.7.3. Mexico: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
9.3. Europe
  9.3.1. Europe: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  9.3.2. Europe: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
  9.3.3. Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  9.3.4. Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.5. U.K.
    9.3.5.1. U.K.: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.5.2. U.K.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.5.3. U.K.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.6. Germany
    9.3.6.1. Germany: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.6.2. Germany: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.6.3. Germany: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.7. France
    9.3.7.1. France: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.7.2. France: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.7.3. France: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.8. Italy
    9.3.8.1. Italy: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.8.2. Italy: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.8.3. Italy: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.9. Spain
    9.3.9.1. Spain: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.9.2. Spain: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.9.3. Spain: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.10. BeNeLux
    9.3.10.1. BeNeLux: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.10.2. BeNeLux: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.10.3. BeNeLux: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.11. Russia
    9.3.11.1. Russia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.11.2. Russia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.11.3. Russia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.3.12. Rest of Europe
    9.3.12.1. Rest of Europe: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.3.12.2. Rest of Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.3.12.3. Rest of Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
9.4. Asia Pacific
  9.4.1. Asia Pacific: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  9.4.2. Asia Pacific: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
  9.4.3. Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  9.4.4. Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.5. China
    9.4.5.1. China: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.5.2. China: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.5.3. China: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.6. Japan
    9.4.6.1. Japan: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.6.2. Japan: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.6.3. Japan: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.7. Australia
    9.4.7.1. Australia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.7.2. Australia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.7.3. Australia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.8. India
    9.4.8.1. India: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.8.2. India: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.8.3. India: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.9. South Korea
    9.4.9.1. South Korea: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.9.2. South Korea: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.9.3. South Korea: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.10. Malaysia
    9.4.10.1. Malaysia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.10.2. Malaysia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.10.3. Malaysia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.11. Thailand
    9.4.11.1. Thailand: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.11.2. Thailand: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.11.3. Thailand: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.12. Indonesia
    9.4.12.1. Indonesia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.12.2. Indonesia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.12.3. Indonesia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.4.13. Rest of Asia Pacific
    9.4.13.1. Rest of Asia Pacific: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.4.13.2. Rest of Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.4.13.3. Rest of Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
9.5. South America
  9.5.1. South America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  9.5.2. South America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
  9.5.3. South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  9.5.4. South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.5.5. Brazil
    9.5.5.1. Brazil: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.5.5.2. Brazil: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.5.5.3. Brazil: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.5.6. Argentina
    9.5.6.1. Argentina: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.5.6.2. Argentina: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.5.6.3. Argentina: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.5.7. Rest of South America
    9.5.7.1. Rest of South America: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.5.7.2. Rest of South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.5.7.3. Rest of South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
9.6. Middle East & Africa
  9.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2034 ($ Million)
  9.6.2. Middle East & Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
  9.6.3. Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
  9.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.6.5. Saudi Arabia
    9.6.5.1. Saudi Arabia: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.6.5.2. Saudi Arabia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.6.5.3. Saudi Arabia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.6.6. UAE
    9.6.6.1. UAE: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.6.6.2. UAE: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.6.6.3. UAE: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.6.7. Egypt
    9.6.7.1. Egypt: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.6.7.2. Egypt: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.6.7.3. Egypt: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.6.8. South Africa
    9.6.8.1. South Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.6.8.2. South Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.6.8.3. South Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)
  9.6.9. Rest of Middle East & Africa
    9.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Product, 2021 – 2034 ($ Million)
    9.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
    9.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million)

CHAPTER 10. COMPETITIVE LANDSCAPE

10.1. Competitior Benchmarking 2023
10.2. Market Share Analysis, 2023
10.3. Key Developments Analysis By Top 5 Companies
10.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 11. COMPANY PROFILES

11.1. Leica Biosystems Nussloch GmbH
  11.1.1. Business Overview
  11.1.2. Financial Analysis
    11.1.2.1. Business Segment Revenue, 2023
    11.1.2.2. Geographic Revenue Mix, 2023
  11.1.3. Product Portfolio
  11.1.4. Recent Development and Strategies Adopted
  11.1.5. SWOT Analysis
11.2. Hamamatsu Photonics Inc.
  11.2.1. Business Overview
  11.2.2. Financial Analysis
    11.2.2.1. Business Segment Revenue, 2023, (% Share)
    11.2.2.2. Geographic Revenue Mix, 2023
  11.2.3. Product Portfolio
  11.2.4. Recent Development and Strategies Adopted
  11.2.5. SWOT Analysis
11.3. Koninklijke Philips N.V
  11.3.1. Business Overview
  11.3.2. Financial Analysis
    11.3.2.1. Business Segment Revenue, 2023
    11.3.2.2. Geographic Revenue Mix, 2023
  11.3.3. Product Portfolio
  11.3.4. Recent Development and Strategies Adopted
  11.3.5. SWOT Analysis
11.4. Olympus Corporation
  11.4.1. Business Overview
  11.4.2. Financial Analysis
    11.4.2.1. Business Segment Revenue, 2023
    11.4.2.2. Geographic Revenue Mix, 2023
  11.4.3. Product Portfolio
  11.4.4. Recent Development and Strategies Adopted
  11.4.5. SWOT Analysis
11.5. Hoffmann-La Roche Ltd
  11.5.1. Business Overview
  11.5.2. Financial Analysis
    11.5.2.1. Business Segment Revenue, 2023
  11.5.3. Product Portfolio
  11.5.4. Recent Development and Strategies Adopted
  11.5.5. SWOT Analysis
11.6. Mikroscan Technologies Inc
  11.6.1. Business Overview
  11.6.2. Product Portfolio
  11.6.3. Recent Development and Strategies Adopted
11.7. Inspirata, Inc
  11.7.1. Business Overview
  11.7.2. Product Portfolio
  11.7.3. Recent Development and Strategies Adopted
11.8. Epredia (3DHISTECH Ltd.)
  11.8.1. Business Overview
  11.8.2. Product Portfolio
  11.8.3. Recent Development and Strategies Adopted
11.9. Visiopharm A/S
  11.9.1. Business Overview
  11.9.2. Product Portfolio
  11.9.3. Recent Development and Strategies Adopted
11.10. Huron Technologies International Inc
  11.10.1. Business Overview
  11.10.2. Product Portfolio
  11.10.3. Recent Development and Strategies Adopted